After silencing circ_0001667, the malignant progression and chemotherapeutic resistance of DOX-resistant breast cancer were inhibited by the miR-4458/NCOA3 (Nuclear receptor coactivator 3) axis [114]. Here, NCOA3 is linked to breast cancer.